The mechanism of Cytochrome P450 3A4 mediated metabolism of (S)-N- [1-(3-morpholin-4ylphenyl)ethyl]-3-phenylacrylamide and its difluoro analogue have been investigated by density functional QM calculations aided with molecular mechanics/molecular dynamics simulations. In this article, we mainly focus on the metabolism of the morpholine ring of substrates 1 and 2. The reaction proceeds via a hydrogen atom abstraction from the morpholine ring by Compound I on a doublet potential energy surface. A transition state was observed at an O-H distance of 1.46 Å for 1 while 1.38 Å for 2. Transition state for the rebound mechanism was not observed. The energy barrier for the hydrogen atom abstraction from 1 was found to be 7.01 kcal/mol in gas phase while 19.53 kcal/mol when the protein environment was emulated by COSMO. Similarly the energy barrier for substrate 2 was found to be 11.07 kcal/mol in gas phase while it was reduced to 12.99 kcal/mol in protein environment. Our previous study reported energy barriers for phenyl hydroxylation of 7.4 kcal/mol. Large energy barriers for morpholine hydroxylation indicates that hydroxylation at the phenyl ring may be preferred over morpholine. MD simulations in protein environment indicated that hydrogen atom at C4 position of phenyl ring remains in closer proximity to oxyferryl oxygen of the heme moiety as compared to morpholine hydrogen and hence greater chance to metabolize at phenyl ring.
Introduction
Cytochromes P450 (CYPs) constitute a superfamily of monooxygenases found in almost all living species.
1) It plays a critical role by metabolizing a wide range of endogenous and exogenous compounds, which include pollutants, environmental compounds, and drug molecules.
2) Several isoforms of CYP are found which perform a variety of functions, such as detoxification of xenobiotics as well as biosynthesis of sex hormones, muscle relaxing, anti-inflammatory, and antihypertensive compounds. It catalyzes several kinds of reactions including aliphatic and aromatic hydroxylation, epoxidation, and heteroatom oxidation. Hydroxylation of drug metabolism is one of the most critical problems faced by pharmaceutical companies. For a safe drug development, it is very important to know the mechanism of the biotransformation of the plausible pharmaceuticals and other xenobiotics.
The reaction cycle of CYP is complicated, involving a number of individual steps, each of which can be ratelimiting depending on the specific reaction and enzyme. This means that the actual oxidation step is not always the ratelimiting one in the overall catalytic cycle of CYP enzymes. However, if alternative products can be formed from a given substrate, differences in reactivity will be observed. Recently a few comprehensive reviews have been published on the CYP subject. [3] [4] [5] The putative catalytically active species involved in hydroxylation is assumed to be an oxoiron(IV) porphyrin radical cation, called Compound I (Cpd I), 4, 6) in analogy to the corresponding chloroperoxidase (CPO) Compound I species. CYP Cpd I have not been detected unambiguously due to its high reactivity, although there is indirect evidence for its existence. 7, 8) Experimental observations on CPO Cpd I suggest that it has a doublet ground state with two parallel unpaired electrons on the iron-oxo moiety and an antiparallel electron in a -orbital of the porphyrin ligand. Theoretical studies 3, 4) predict that the ground state of Cpd I in the protein is a quasi-degenerate pair of triradicaloid states, labeled 2 A 2u and 4 A 2u . They only differ in the spin coupling between the electronic triplet on the iron-oxo moiety and an electron in the a 2u -like () orbital of the porphyrin ring.
Hydroxylation of aliphatic substrates by Cpd I is believed to proceed with hydrogen abstraction and oxygen rebound mechanism.
6) A generally accepted mechanism for aliphatic hydroxylation by CYP involves the initial hydrogen atom abstraction from a C-H bond of the substrate, followed by the recombination of the resultant radical species to form the hydroxylated product. In contrast to aliphatic hydroxylation, aromatic hydroxylation only occurs on the low-spin surface and proceeds predominantly through an electrophilic pathway via a cation-like -complex intermediate. It was also found that the rearrangement of the cationic intermediate to phenol and ketone can be catalyzed directly by the enzyme through the N-protonated porphyrin intermediate, which serves as a proton shuttle. 3, 9) CYP3A4 is a major isoform and accounts for 30% of the total CYP protein in human liver. It has also broad substrate specificity and is estimated to be involved in he metabolism of almost 50% of drugs used in humans. We have studied the CYP3A4 mediated metabolism pathway for (S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]-3-phenylacrylamide (1) and its difluoro analogue (2) (Figure 1 ), the novel KCNQ2 potassium channel openers. (Fig. 1 ) was found to be orally bioavailable KCNQ2 opener free of CYP3A4 MDI.
11) The existence of a pair of closely related compounds with different MDI properties provides promising material and good guidance for examining details of selected steps in their metabolism.
CYP3A4 MDI studies suggest that reactive intermediate may be formed on the N-phenylmorpholine moiety of 1 and morpholine moiety might be playing an important role in the formation of reactive intermediate. In effect, a complete picture of the key steps of the reaction in general, and hydroxylation reaction in particular at morpholine ring has not emerged so far. These two factors added to the interest focused on novel drug molecules with variable MDI factor and the presence of many question marks in the general reaction mechanism, prompted us to undertake this study. In our previous studies we investigated the metabolism at C4 position of the phenyl ring. [12] [13] [14] It lead us to grasp important information regarding the metabolism reaction in this particular system. In this article the question we attempt to unveil is whether that metabolism occurs only at the phenyl ring or whether there is some possibility that hydroxylation might also occur at the morpholine ring. We also attempt to find the reason why the fluoro analogue of substrate 1 does not form any reactive intermediate. These questions lead us to consider the metabolism pathway for morpholine hydroxylation in substrate 1 as well as in substrate 2. Therefore, here we investigated the possibilities that the metabolism might also occur at the morpholine ring.
Computational Details
Docking studies were carried out using the LigandFit module of Cerius2.
15) CYP3A4 crystal structure bound with Metyrapone ligand was used for docking (PDB Id: 1W0G). 16) Conformation of the docked ligand was selected on the basis of visual inspection and the ligandfit score. Conformation of the bound ligand was selected also keeping in mind experimental evidence, which suggests that metabolism occurs at the N-phenylmorpholine moiety. Hydrogen's were added for full protein and minimization was carried out using Discover module of INSIGHT II. Parameters for heme and oxyheme were added in the CVFF force field. 17) After minimization, molecular dynamics simulation was carried out using our in house program NEW-RYUDO. [18] [19] [20] [21] MD simulations were carried out for 500000 steps with a step size of 0.1 fs and temperature of 298 K. Furthermore, many geometrical parameters were also analyzed throughout the simulation.
Quantum chemical calculations and auxiliary stud-
ies All quantum chemical calculations were done by means of the DMol 3 software, 22, 23) implemented in Materials Studio 2.2 software by Accelrys Inc.: San Diego, CA. Our initial gas phase QM model was cut-off from the active site with the bound substrate obtained by docking studies. We used a sixcoordinated complex Fe
as a Cpd I model of CYP. The cysteine amino acid bound to the heme group was replaced with a SCH 3 group. Total charge of the reacting system is neutral. All calculations were carried out for doublet spin states. Double numerical basis set with polarization functions (denoted as DNP in the software) was used in combination with GGA PW91 exchange-correlation functionals. The calculations were fully unrestricted and the electronic configuration was carefully checked for all stable structures. The transformation mechanism between stable structures was followed by minimum energy pathway calculations based on geometrically selected reaction coordinates (DRC). In this part of the study local exchangecorrelation functional VWN was used for calculations following the reaction pathway and only the transition state neighbourhood was recalculated with GGA. The electronic structure of the system along the reaction pathways was allowed to smear within 0.01 au window around the Fermi level to avoid convergence problems, with full control of total spin. The reaction coordinate for each step of the reaction was defined as the distance between the oxyferryl oxygen of Cpd I and hydrogen of morpholine ring. The model investigated here is large and the potential energy profiles in the vicinity of transition states are usually flat thus frequency calculations were technically demanding and not feasible with resources at hand. Charges and spin populations were calculated by Hirshfeld and Mulliken population analysis; visualisation and 3D plots were done using the Materials Studio package. Electronic effects of protein environment were taken into account approximately by computing single point energies using conductor-like solvation model COSMO at the GGA-PW91 level. 24, 25) In this model, a cavity around the system is surrounded by a polarizable dielectric continuum. The dielectric constant was set to 5.7, which represents reasonably well the protein environment. The cavity in the dielectric medium was generated using standard van der Waals radii and a solvent probe radius of 2.6 Å . Figure 2 shows the docked conformation of substrate 1 in the binding site of CYP3A4. From the docked structure it can be observed that two hydrogen's are exposed towards the oxyferryl oxygen of the heme moiety. Phenyl ring C4 hydrogen is 2.89 Å from the oxyheme O while morpholine H is 2.6 Å . Thus, both hydrogen atoms of the substrate 1 are in close proximity, hence, metabolism at morpholine H cannot be ruled out. These observations further lead us to study the hydroxylation pathway for morpholine hydrogen. In our previous study we reported the hydroxylation at the phenyl ring. Hydroxylation at the phenyl ring occurs through electrophilic attack to form a carbocationic -complex.
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The energy barrier for -complex formation was found to be 7.4 kcal/mol. In the case of benzene, the energy barrier was 17-18 kcal/mol. 9) We have attributed significant lowering of the energy barrier for -complex with substrate 1 to the formation of conjugated double bond with morpholine nitrogen in ortho position that should compensate the loss of aromatic stabilization. Two kind of -complexes were formed; in one case the phenyl ring was perpendicular to the porphyrin ring while in the other case it was parallel to the porphyrin ring. The perpendicular strongly bound -complex, further transfers its proton to porphyrin nitrogen to produce a protonated porphyrin moiety called the proton shuttle intermediate. It further rearranges to produce alcohol and ketone products. The parallel -complex further yields ketone product through 1,2 hydride shift.
The optimized structure of Cpd I on its doublet ground state is shown in Fig. 3 . Similar to other theoretical studies, we also found that in Cpd I there are two parallel unpaired electrons on the iron-oxo moiety and an antiparallel electron in a -orbital of the porphyrin ring and SCH 3 group on doublet potential energy surface. 6, 9) The first step of the reaction is hydrogen abstraction. For this step we abstracted H from the morpholine ring and O of Cpd I by decreasing H-O distances for regular intervals. Only doublet spin states were used since previous studies found that a doublet spin state is more favored than a quartet spin state. 3, 9) Table 1 shows the geometrical parameters of the optimized species for the reaction of Cpd I with substrate 1 and 2. Table 2 shows the charges and spin densities along the transformation pathways.
Hydroxylation of substrate 1
In the weakly bound complex, the Fe-O distance is 1.68 Å , H-C is 1.10 Å and the O-H distance is 2.19 Å . In the transition state (TS), the O-H distance becomes 1.46 Å , Fe-O is 1.70 Å and C-O distance is 2.62 Å . During the morpholine hydroxylation a gradual formation of an O-C bond was observed, with the O-C distance going from 3.29 to 2.62 Å in the transition state to 1.45 Å in the hydroxylated product. The energy barrier for this transition state was found to be 7.01 kcal/mol in gas phase while it amounted to 19.53 kcal/ mol in COSMO phase (Fig. 4) . In the solvated phase the energy barrier increased by 12.52 kcal/mol. The high energy barrier in COSMO phase indicates that in the protein environment reaction may proceed with high energy barrier. Table 3 shows the interaction energy data for the oxidation of substrate 1 and 2. After the transition state, the energy decreases leading to the formation of the final product. Hydroxylated intermediate and rebound mechanism as reported previously in the case of aliphatic compounds were not observed in our studies. One possible reason for this observation is that hydroxylation at morpholine ring is not rate determining step on doublet potential energy surface. After the transition state, the C atom directly forms a bond with O to produce the hydroxylated product. This observation differs from previously reported studies.
3) The product is stabilized by 45.25 kcal/mol as compared to the reactant.
Hydroxylation of substrate 2
Weakly bound complex obtained from previous studies were modified to get substrate 2. C4 hydrogen and terminal phenyl ring hydrogen of para carbon atom of 1 was replaced with fluorine atom. Then this complex was submitted for geometry optimization using accurate DFT methods. In the encounter complex, morpholine H and O distance is 2.31 Å . Fe-O distance is 1.67 Å and Fe-S is 2.42 Å as reported in Table 1 . In the encounter complex spin on the porphyrin ring is À0:26 while on the ligand it is À0:1. Charge on the ligand is 0.11, which depicts that charge is transferred from ligand to Cpd I. Transition state consists of O-H distance of 1.38 Å , C-O of 2.54 Å and C-H of 1.19 Å . In the transitions states O spin is reduced from 0.84 to 0.62. Spin on porphyrin ring is À0:21 while on ligand the value is À0:07. H possesses a charge of 0.33 and a small spin of À0:02. SCH 3 group contains spin of À0:47 and almost zero charge. Gradual forming of the C-O bond was observed, where C-O decreases gradually from 3.25 Å in the weakly bound complex to 2.54 Å at the transition state to 1.49 Å in the hydroxylated product. Figure 5 shows the energy barrier profile for hydroxylation of morpholine ring of substrate 2. The energy barrier was found to be 11.07 kcal/mol in gas phase while it increases in the COSMO phase up to the value of 12.99 kcal/mol (Fig. 5) . The transition state leads directly to the formation of the hydroxylated product similar to substrate 1. In the final product the C-O distance remains at 1.49 Å , O-H distance at 0.98 Å and Fe-O distance at 2.23 Å . The spin is mostly concentrated on the Fe atom and the SCH 3 moiety.
In addition to the detailed DFT calculations, analyses of MD trajectories for the full model embedded in the specific protein were carried out. Statistical analysis of MD results for the encounter complex between substrate 1 and oxyferryl active center in CYP3A4 is shown in Table 4 . It can be seen that during most of the simulation time, the average distance between Fe=O and phenyl hydrogen remains at 3.26 Å while for morpholine hydrogen it is 3.46 Å . This observation Table 3 Interaction energy data for substrate 1 and 2 in gas and COSMO phase.
2
Gas phase COSMO Gas phase COSMO clearly indicates that the phenyl hydrogen remains in close proximity of oxyheme moiety as compared to morpholine hydrogen. Hence for metabolism, phenyl hydrogen at C4 position of substrate 1 is more accessible. The overall observation indicates that there is a very low possibility of metabolism of the morpholine ring in case of 1. Energy barrier for 1 is 4 kcal/mol lower than 2 in gas phase while 6.54 kcal/mol higher in COSMO phase. Higher energy barrier in COSMO phase for 1 diminishes the possibility at morpholine ring metabolism. When the phenyl hydrogen of 1 is replaced with fluorine hydrogen in substrate 2, the energy barrier decreases. In substrate 2 where fluorine atom attached to the phenyl ring, morpholine hydroxylation may take place. But experimental observations suggest that substrate 2 is devoid of CYP3A4 metabolism. This indicates that in presence of fluorine atom attached to phenyl ring in substrate 2, morpholine hydroxylation may occur but it may not affect the important pharmacophore required for KCNQ2 potassium channel opener activity.
Conclusion
Hydroxylation of (S)-N-[1-(3-morpholin-4ylphenyl)ethyl]-3-phenylacrylamide and its difluoro analogue was studied by density functional QM calculations aided with molecular mechanics/molecular dynamics simulations. Experimental CYP3A4 metabolism independent studies reveal that substrate (S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]-3-phenylacrylamide metabolizes at the N-phenylmorpholine ring, while its difluoro analogue was orally bioavailable KCNQ2 opener free of CYP3A4 MDI. Docking studies reveal that the two hydrogen atoms of substrate 1 were exposed to the heme moiety, one of them is a phenyl hydrogen and the other is a morpholine ring hydrogen atom. The hydroxylation pathway on morpholine ring for substrate 1 and 2 were studied using DFT level of theory. Energy barrier for hydroxylation pathway on morpholine ring is higher than that for the phenyl ring. Aliphatic hydroxylation occurs through hydrogen abstraction to form hydroxylated product and radical substrate, which further rebound to form hydroxylated product. In our case, we did not observe any hydroxylated product and rebound mechanism. Hence one possible reason may be that hydroxylation of morpholine is different than other aliphatic metabolism reaction. More analysis will indeed be necessary to show the exact mechanism for morpholine kind of hydroxylation. This will be the theme for our next research investigation. Analysis of molecular dynamics simulation also supports that phenyl hydrogen remains in close proximity of Fe-O moiety of Cpd I as compared to the morpholine hydrogen. Hence in substrate 1 hydroxylation at phenyl ring is energetically more preferred over morpholine ring hydroxylation. Our result also validates the experimental findings that hydroxylation at phenyl ring occurs in phase 1 of the reaction catalyzed by CYP3A4. Later in phase 2 reaction, it again undergoes reactions to form toxic metabolites. Thus, we can conclude that enhancing or suppressing the drug metabolism for substrate 1 should concentrate on this fragment. 
